JP2024517710A5 - - Google Patents
Info
- Publication number
- JP2024517710A5 JP2024517710A5 JP2023565854A JP2023565854A JP2024517710A5 JP 2024517710 A5 JP2024517710 A5 JP 2024517710A5 JP 2023565854 A JP2023565854 A JP 2023565854A JP 2023565854 A JP2023565854 A JP 2023565854A JP 2024517710 A5 JP2024517710 A5 JP 2024517710A5
- Authority
- JP
- Japan
- Prior art keywords
- targeted peptide
- modified
- modified aav
- capsid protein
- aav according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163180394P | 2021-04-27 | 2021-04-27 | |
| US63/180,394 | 2021-04-27 | ||
| PCT/US2022/026518 WO2022232257A1 (en) | 2021-04-27 | 2022-04-27 | Adeno-associated viral vectors for transduction of cochlea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517710A JP2024517710A (ja) | 2024-04-23 |
| JP2024517710A5 true JP2024517710A5 (https=) | 2025-04-21 |
Family
ID=83847287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565854A Pending JP2024517710A (ja) | 2021-04-27 | 2022-04-27 | 蝸牛に形質導入するためのアデノ随伴ウイルスベクター |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240197920A1 (https=) |
| EP (1) | EP4330413A4 (https=) |
| JP (1) | JP2024517710A (https=) |
| KR (1) | KR20240004536A (https=) |
| AU (1) | AU2022264006A1 (https=) |
| CA (1) | CA3216591A1 (https=) |
| WO (1) | WO2022232257A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121816425A (zh) * | 2023-09-11 | 2026-04-07 | 学校法人顺天堂 | 能够感染内耳的aav变体 |
| US20250152747A1 (en) * | 2023-11-15 | 2025-05-15 | Genzyme Corporation | Methods of treating gaucher disease and gba-parkinson’s disease |
| US20250152744A1 (en) * | 2023-11-15 | 2025-05-15 | Genzyme Corporation | Methods of treating neurodegenerative disorders |
| WO2025170984A1 (en) * | 2024-02-05 | 2025-08-14 | The Children's Hospital Of Philadelphia | Cell-type-specific control of gene expression in auditory hair cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3762040A4 (en) * | 2018-03-05 | 2022-01-05 | Children's Medical Center Corporation | COMPOSITIONS AND METHODS OF ADMINISTRATION OF NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS |
| WO2020077295A1 (en) * | 2018-10-11 | 2020-04-16 | Decibel Therapeutics, Inc. | Aav1 vectors and uses thereof for treatment of otic indications |
| WO2021067448A1 (en) * | 2019-09-30 | 2021-04-08 | Applied Genetic Technologies Corporation | Adeno-associated virus (aav) systems for treatment of genetic hearing loss |
| AU2020366531A1 (en) * | 2019-10-18 | 2022-05-26 | Research Institute At Nationwide Children's Hospital | Gene therapy targeting cochlear cells |
| WO2021231538A2 (en) * | 2020-05-13 | 2021-11-18 | Akouos, Inc. | Compositions and methods for treating kcnq4-associated hearing loss |
-
2022
- 2022-04-27 EP EP22796629.8A patent/EP4330413A4/en active Pending
- 2022-04-27 US US18/557,033 patent/US20240197920A1/en active Pending
- 2022-04-27 AU AU2022264006A patent/AU2022264006A1/en active Pending
- 2022-04-27 WO PCT/US2022/026518 patent/WO2022232257A1/en not_active Ceased
- 2022-04-27 KR KR1020237039604A patent/KR20240004536A/ko active Pending
- 2022-04-27 CA CA3216591A patent/CA3216591A1/en active Pending
- 2022-04-27 JP JP2023565854A patent/JP2024517710A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024517710A5 (https=) | ||
| TWI832036B (zh) | 用於aav之遞送之組合物及方法 | |
| JP2022526018A5 (https=) | ||
| JP2021532812A5 (https=) | ||
| CN107207556B (zh) | 调节性多核苷酸 | |
| JP2024540221A (ja) | Ａａｖカプシドバリアント及びその使用 | |
| JP2022501040A5 (https=) | ||
| JP2025179046A5 (https=) | ||
| JP2022141670A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| JP2023515072A5 (https=) | ||
| JP2021513863A5 (https=) | ||
| RU2018120736A (ru) | Нацеливающие пептиды для направленной доставки аденоассоциированных вирусов (aav) | |
| JP2020526514A5 (https=) | ||
| CN114848850B (zh) | Rs1基因在制备xlrs治疗剂中的应用及治疗剂 | |
| Lustig et al. | Cochlear gene therapy | |
| JP2022519623A5 (https=) | ||
| AU2019299861A1 (en) | Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord | |
| JP2021500922A5 (https=) | ||
| JP2020105169A5 (https=) | ||
| JP2023534037A5 (https=) | ||
| JP2022553573A5 (https=) | ||
| WO2021247995A2 (en) | Compositions and methods of treating neuropathic pain | |
| JP2020527167A5 (https=) | ||
| CA3178591A1 (en) | Immunosuppressive agents and viral delivery re-dosing methods for gene therapy |